98%
921
2 minutes
20
Introduction: The clinical utility of dementia prognostic scores has limited validity across diverse populations. This study aimed to enhance the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) model by incorporating resting heart rate (RHR) using a machine learning method across a diverse population.
Methods: We developed CAIDE and CAIDE-RHR models using a random forest algorithm in the National Alzheimer's Coordinating Center (NACC) dataset. Model performances were assessed using area under the receiver-operating characteristic curve (AUC), Matthew's correlation coefficient (MCC), and the Brier score.
Results: Incorporating RHR into the CAIDE model significantly improved predictive accuracy across Black African, Asian, White, and Native Hawaiian populations (mean AUC range: 0.80-0.91). However, this improvement was not observed in the American Indian population, where the AUC decreased from 0.87 to 0.84.
Discussion: Our findings highlight significant ethnic differences in dementia risk prediction models. These results underscore the need for validating and tailoring dementia risk scores to ensure applicability across diverse races.
Highlights: Incorporating resting heart rate (RHR) into the Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) model significantly improves its predictive accuracy for dementia risk across diverse populations, offering a novel addition to dementia risk models. The application of the machine learning technique enhances dementia risk prediction by capturing complex, non-linear relationships among variables. The improved model enables more precise early identification of individuals at risk of cognitive decline, supporting preventive strategies in dementia care. Resting heart rate, a simple and non-invasive cardiovascular measure, is demonstrated to be a valuable predictor for dementia risk, making it practical for clinical application.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12332766 | PMC |
http://dx.doi.org/10.1002/alz.70442 | DOI Listing |
PLoS One
September 2025
Department of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Background: Stroke is a leading cause of death and disability globally, with frequent cognitive sequelae affecting up to 60% of stroke survivors. Despite the high prevalence of post-stroke cognitive impairment (PSCI), early detection remains underemphasized in clinical practice, with limited focus on broader neuropsychological and affective symptoms. Stroke elevates dementia risk and may act as a trigger for progressive neurodegenerative diseases.
View Article and Find Full Text PDFJ Alzheimers Dis
September 2025
Amsterdam Public Health, Aging & Later life and Personalized Medicine, Amsterdam, the Netherlands.
BackgroundAllostatic load (AL), an umbrella term for the physiological response to chronic stress, is different in women and men. AL has also been associated with all-cause dementia.ObjectiveThe current study investigates if AL clusters differently in men and women, and if these sex-based clusters are associated with all-cause dementia.
View Article and Find Full Text PDFJ Alzheimers Dis
September 2025
Institute for Public Health Genetics, University of Washington, Seattle, WA, USA.
Genetic risk prediction for Alzheimer's disease (AD) has high potential impact, yet few studies have assessed the reliability of various polygenic risk score (PRS) methods at the individual level. Here, we evaluated the reliability of AD PRS estimates among 6338 participants from the Multi-Ethnic Study of Atherosclerosis. We compared four PRS models that have been previously associated with dementia risk.
View Article and Find Full Text PDFJ Alzheimers Dis
September 2025
The Framingham Heart Study, Framingham, MA, USA.
BackgroundWomen have a higher risk of dementia than men. Reproductive factors may be implicated.ObjectiveDetermine the association between reproductive factors (earlier menarche, later menopause, longer reproductive lifespan (RLS), post-menopausal hormone replacement therapy [pmHRT] use, and serum estradiol/estrone) and neurocognitive and neuroimaging markers of brain aging and incident dementia in cognitively healthy women.
View Article and Find Full Text PDFCNS Drugs
September 2025
Global Health Neurology Lab, Sydney, NSW, 2150, Australia.
Acute ischemic stroke (AIS) remains a leading cause of mortality and long-term disability globally, with survivors at high risk of recurrent stroke, cardiovascular events, and post-stroke dementia. Statins, while widely used for their lipid-lowering effects, also possess pleiotropic properties, including anti-inflammatory, endothelial-stabilizing, and neuroprotective actions, which may offer added benefit in AIS management. This article synthesizes emerging evidence on statins' dual mechanisms of action and evaluates their role in reducing recurrence, improving survival, and mitigating cognitive decline.
View Article and Find Full Text PDF